Cypress Capital Group Has $7.54 Million Holdings in CME Group Inc. (NASDAQ:CME)

Cypress Capital Group lifted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 1.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 34,190 shares of the financial services provider’s stock after purchasing an additional 373 shares during the quarter. CME Group accounts for 0.8% of Cypress Capital Group’s holdings, making the stock its 29th largest position. Cypress Capital Group’s holdings in CME Group were worth $7,544,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Primecap Management Co. CA lifted its position in CME Group by 3.3% during the third quarter. Primecap Management Co. CA now owns 1,861,690 shares of the financial services provider’s stock worth $410,782,000 after purchasing an additional 58,647 shares during the period. Intech Investment Management LLC lifted its holdings in shares of CME Group by 46.2% during the 3rd quarter. Intech Investment Management LLC now owns 22,830 shares of the financial services provider’s stock worth $5,037,000 after acquiring an additional 7,214 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in shares of CME Group by 2.6% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 278,127 shares of the financial services provider’s stock worth $61,369,000 after acquiring an additional 6,923 shares during the period. Citizens Financial Group Inc. RI boosted its position in shares of CME Group by 9.4% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 1,369 shares of the financial services provider’s stock worth $302,000 after acquiring an additional 118 shares in the last quarter. Finally, Bellwether Advisors LLC bought a new position in CME Group in the third quarter valued at approximately $6,527,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. This represents a 15.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 in the last quarter. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. The Goldman Sachs Group boosted their target price on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Bank of America upped their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday, October 24th. Finally, Barclays increased their price target on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $224.47.

CME Group Price Performance

CME Group stock opened at $228.00 on Thursday. The firm has a market cap of $82.16 billion, a P/E ratio of 23.97, a P/E/G ratio of 5.30 and a beta of 0.55. The stock’s 50 day moving average is $223.21 and its 200 day moving average is $210.81. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $230.74.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company posted $2.25 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, research analysts expect that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be paid a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.02%. CME Group’s dividend payout ratio is currently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.